Symposium overview: The role of genetic polymorphism and repair deficiencies in environmental disease

Toxicological Sciences

Volumn 47, Issue 2, 1999, Pages 135-143

  Hulla, J E ^a   Miller, M S ^b   Taylor, J A ^c   Hein, D W ^d   Furlong, C E ^e   Omiecinski, C J ^e   Kunkel, T A ^c  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d University of Louisville School of Medicine   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cancer; DNA polymerase; Environment; Epoxide hydrolase; Mism atch repair; N acetyltransferase; Paraoxonase; Polymorphism; Predisposition; Susceptibility

Indexed keywords

2',3 DIMETHYL 4 BIPHENYLAMINE; ACYLTRANSFERASE; ARYLDIALKYLPHOSPHATASE; CARCINOGEN; COMPLEMENTARY DNA; DNA POLYMERASE; EPOXIDE HYDROLASE; HETEROCYCLIC AMINE; MICROSOME ENZYME; ORGANOPHOSPHATE INSECTICIDE;

BLADDER CANCER; CANCER SUSCEPTIBILITY; COLON CANCER; CONTROLLED STUDY; DETOXIFICATION; DISEASE PREDISPOSITION; DNA REPAIR; DNA REPLICATION; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; LIVER MICROSOME; NONHUMAN; REVIEW; XENOBIOTIC METABOLISM;

EID: 0032906829     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/47.2.135     Document Type: Review

References (90)

1. Adams, J. D., Jr., Yagi, H., Levin, W., and Jerina, D. M. (1995). Stereo-selectivity and regio-selectivity in the metabolism of 7,8-dihydrobenzo-[a]pyrene by cytochrome P450, epoxide hydrolase and hepatic microsomes from 3-methylcholanthrene-treated rats. Chem. Biol. Interact. 95, 57-77.
2. Augustinsson, K. B., and Barr, M. (1963). Age variation in plasma arylesterase activity in children. Clin. Chim. Acta 8, 568-573.
3. Badawi, A. F., Bell, D.A., Hirvonen, A., and Kadlubar, F. (1995). Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res. 55, 5230-5237.
4. Beard, W. A., Osherhoff, W. P., Prasad, R., Sawaya, M. R., Jaju, M., Wood, T. G., Kraut, J., Kunkel, T. A., and Wilson, S. H. (1996) Enzyme-DNA interactions required for efficient nucleotide incorporation and discrimination in human DNA polymerase beta. J Biol Chem 271, 12141-12144.
5. Bebenek, K., Beard, W. A., Darden, T. A., Li, L., Prasad, R., Luxon, B. A., Gorenstein, D. G., Wilson, S. H., and Kunkel, T. A. (1997). A minor groove binding track in reverse transcriptase. Nat. Struct. Biol. 4, 194-197.
6. Beetham, J. K., Grant, D., Arand, M., Garbarino, J., Kiyosue, T., Pinot, F., Oesch, F., Belknap, W. R., Shinozaki, K., and Hammock, B. D. (1995). Gene evolution of epoxide hydrolases and recommended nomenclature. DNA Cell. Biol. 14, 61-71.
7. Bell, D. A., Badawi, A. F., Lang, N. P., Ilett, K. F., Kadlubar, F., and Hirvonen, A. (1995a). Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: Association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue samples. Cancer Res. 55, 5226-5229.
8. Bell, D. A., Stephens, E., Castranio, T., Umbach, D. M., Watson, M., Deakin, M., Elder, J., Duncan, H., Hendrickse, C., and Strange, R. C. (1995b). Polyadenylation polymorphism in the N-acetyltransferase gene 1 (NAT1) increases risk of colorectal cancer. Cancer Res. 55, 3537-3542.
9. Bell, J. B., Eckert, K. A., Joyce, C. M., and Kunkel, T. A. (1997). Base miscoding and strand misalignment errors by mutator Klenow polymerases with amino acid substitutions at tyrosine 766 in the O helix of the fingers subdomain. J. Biol. Chem. 272, 7345-7351.
10. Brockmoller, J., Cascorbi, I., Kerb, R., and Roots, I. (1996). Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res. 56, 3915-3925.
11. Butcher, N. J., Ilett, K. F., and Minchin, R. F. (1998). Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations. Pharmacogenetics 8, 67-72.
12. Davies, H., Richter, R. J., Keifer, M., Broomfield, C., Sowalla, J., and Furlong, C. E. (1996). The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 14, 334-336.
13. Delomenie, C., Goodfellow, G. H., Krishnamoorthy, R., Grant, D. M., and Dupret, J.-M. (1997). Study of the role of the highly conserved residues Arg9 and Arg64 in the catalytic function of human N-acetyltransferases NAT1 and NAT2 by site-directed mutagenesis. Biochem. J. 323, 207-215.
14. Doll, M. A., and Hein, D. W. (1995). Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred rats. Pharmacogenetics 5, 247-251.
15. Doll, M. A., Jiang, W., Deitz, A. C., Rustan, T. D., and Hein, D. W. (1997). Identification of a novel allele at the human NAT1 acetyltransferase locus. Biochem. Biophys. Res. Commun. 233, 584-591.
16. Eckerson, H. W., Romson, J., Whyten, C. M., and La Du, B. N. (1983). The human serum paraoxonase polymorphism: Identification of phenotypes by their response to salts. Am. J. Hum. Genet. 35, 14-227.
17. Feng, Y., Fretland, A. J., Rustan, T. D., Jiang, W., Becker, W. K., and Hein, D. W. (1997). Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2'-dimethyl-4-aminobiphenyl. Toxicol. Appi. Pharmacol. 147, 56-62.
18. Feng, Y., Wagner, R. J., Fretland, A. J., Becker, W. K., Cooley, A. M., Pretlow, T. P., Lee, K. J., and Hein, D. W. (1996). Acetylator genotype (NAT2)-dependent formation of aberrant crypts in congenic Syrian hamsters administered 3,2'-dimethyl-4-aminobiphenyl. Cancer Res. 56, 527-531.
19. Ferguson, R. J., Doll, M. A, Baumstark, B. R., and Hein, D. W. (1994a). Polymorphic arylamine N-acetyltransferase encoding gene (NAT2) from homozygous rapid and slow acetylator congenic Syrian hamsters. Gene 140, 247-249.
20. Ferguson, R. J., Doll, M. A., Rustan, T. D, Gray, K., and Hein, D. W. (1994b). Cloning, expression, and functional characterization of two mutant (NAT2 191 and NAT2 341/803) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles. Drug Metab Dispos 22, 371-376.
21. Ferguson, R. J., Doll, M. A., Rustan, T. D., and Hein, D. W. (1996). Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyltransferase encoding genes of the Syrian hamster. Pharmacogenetics 6, 55-66.
22. Furlong, C. E., Richter, R. J., Seidel, S. L., Costa, L. G., and. Motulsky, A. G. (1989). Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. 1989. Anal. Biochem. 180, 242-247.
23. Gaedigk, A., Spielberg, S. P., and Grant, D. M. (1994). Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. Pharmacogenetics 4, 142-153.
24. Geldmacher-von Mallinkrodt, M., and Diepgen, T. L. (1988). The human serum paraoxonase-polymorphism and specificity. Toxicol Environ. Chem. 18, 79.
25. Gil, J. P., and Lechner, M. C, (1998). Increased frequency of wild-type arylamine-N-acetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer. Carcinogenesis 19, 37-41.
26. Guengerich, F. P. (1982). Epoxide hydrolase: Properties and metabolic roles. Reviews in Biochemical Toxicology 4, 5-30.
27. Hassett, C., Aicher, L., Sidhu, J. S., and Omiecinski, C.J. (1994). Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants [published erratum appears in Hum. Mol. Genet. 3, 1214]. Hum. Mol. Genet. 3, 421-428.
28. Hassett, C., Laurenzana, E. M., Sidhu, J. S., and Omiecinski, C. J. (1998). Effects of chemical inducers on human microsomal epoxide hydrolase in primary hepatocyte cultures. Biochem. Pharmacol. 55, 1059-1069.
29. Hassett, C., Lin, J., Carty, C. L., Laurenzana, E. M., and Omiecinski, C. J. (1997). Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. Arch. Biochem. Biophys. 337, 275-283.
30. Hassett, C., Richter, R. J., Humbert, R., Chapline, C., Crabb, J. W., Omiecinski, C. J., and Furlong, C. E. (1991). Characterization of cDNA clones encoding rabbit and human serum paraoxonase: The mature protein retains its signal sequence. Biochemistry 30, 1041-1049.
31. Hassett, C., Robinson, K. B., Beck, N. B., and Omiecinski, C. J. (1994). The human microsomal epoxide hydrolase gene (EPHX1): Complete nucleotide sequence and structural characterization. Genomics 23, 433-442.
32. Hein, D. W. (1988). Acetylator genotype and arylamine-induced carcinogenesis. Biochim. Biophys. Acta 948, 37-66.
33. Hein, D. W., Doll, M. A., Rustan, T. D., Gray, K., Feng, Y., Ferguson, R. J., and Grant, D. M. (1993). Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 14, 1633-1638.
34. Hein, D. W., Doll, M. A., Fretland, A. J., Gray, K., Deitz, A. C., Feng, Y., Jiang, W., Rustan, T. D., Satran, S., and Wilkie, T. R. (1997). Rodent models of the human acetylation polymorphism: Comparisons of recombinant acetyltransferases. Mut. Res. 376, 101-106.
35. Hein, D. W., Doll, M. A., Fretland, A. J., and Leff, M. A. (1998). Metabolic activation of N-hydroxy-2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (N-OH-PhIP) by twenty-three recombinant human NAT2 allozymes. Proc. Amer. Assoc. Cancer Res, 39, 455.
36. Hein, D. W., Doll, M. A, Rustan, T. D., and Ferguson, R. J. (1995). Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: Effects of 7 specific NAT2 nucleic acid substitutions. Cancer Res. 55, 3531-3536.
37. Hein, D. W., Ferguson, R. J., Doll, M. A., Rustan, T. D., and Gray, K. (1994a). Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant human wild-type, mutant, and chimeric NAT2 allozymes. Hum. Molec. Genet. 3, 729-734.
38. Hein, D. W., Rustan, T. D., Ferguson, R. J., Doll, M. A., and Gray, K. (1994b). Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Arch. Toxicol. 68, 129-133.
39. Hermann, J. G., Umar, A., Polyak, K., Ahuja, N., Graff, J. R., Ahuja, N., Issa, J.-P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. K., Kolodner, R. D., Vogelstein, B., Kunkel, T. A., and Baylin, S. B. (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. U S A 95 (in press).
40. Hickman, D., Palamanda, J. R., Unadkat, J. D., and Sim, E. (1995). Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in Escherichia coli. Biochem. Pharmacol. 50, 697-703.
41. Hubbard, A. L., Harrison, D. J., Moyes, C., Wyllie, A. H., Cunningham, C., Mannion, E., and Smith, C. A. D. (1997). N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut 41, 229-234.
42. Hughes, N. C., Janezic, S. A., McQueen, K. L., Jewett, M. A. S., Castranio, T., Bell, D. A., and Grant, D. M. (1998). Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in vivo and in vitro probe. Pharmacogenetics 8, 55-66.
43. Humbert, R., D.A. Adler, C.M. Disteche, C. Hassett, C.J. Omiecinski and C.E. Furlong. 1993. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3, 73-376.
44. Ilett, K. F., David. B. M., Dethon, P., Castleden, W. M., and Kwa, R. (1987). Acetylator phenotype in colorectal carcinoma. Cancer Res. 47, 1466-1469.
45. Ito, N., Hasegawa, R., Sano, M., Tamano, S., Esumi, H., Takayama, S., and Sugimura, T. (1991). A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP). Carcinogenesis 12, 1503-1506.
46. Kaiser, J. (1997). Environment institute lays plans for gene hunt. Science 278, 569-570.
47. Kunkel, T. A., and Wilson, S. H. (1998). DNA polymerases on the move. Nat. Struct. Biol. 5, 95-99.
48. Ladero, J. M., Gonzalez, J. F., Benitez, J., Vargas, E., Fernandez, M. J., Baki, W., and Diaz-Rubio, M. (1991). Acetylator polymorphism in human colorectal carcinoma. Cancer Res. 51, 2098-2100.
49. Lancaster, J. M., Brownlee, H. A., Bell, D. A., Futreal, P. A., Marks, J. R., Berchuck, A., Wiseman, R. W., and Taylor, J. A. (1996). Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol. Carcinog. 17, 160-162.
50. Lang, N. P., Butler, M. A., Massengell, J., Lawson, M., Stotts, R. C., Hauer-Jensen, J., and Kadlubar, F. F. (1994). Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increases the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prev. 3, 675-682.
51. Lang, N. P., Chu, D. Z., Hunter, C. F., Kendall, D. C., Flammang, T. J., and Kadlubar, F. F. (1986). Role of aromatic amine acetyltransferase in human colorectal cancer. Arch. Surg. 121, 1259-1261.
52. Laurenzana, E. M., Hassett, C., and Omiecinski, C. J. (1998). Post-transcriptional regulation of human microsomal epoxide hydrolase. Pharmacogenetics (in press).
53. Layton, D. W., Bogen, K. T., Knize, M. G., Hatch, F. T., Johnson, V. M.,. and Felton, J. S. (1995). Cancer risk of heterocyclic amines in cooked foods: An analysis and implications for research. Carcinogenesis 16, 39-52.
54. Li, W.-F., C. Matthews, C. M. Disteche, L. G. Costa and C. E. Furlong. 1997. Paraoxonase (PON1) gene in mice: Sequencing, chromosomal localization and developmental expression. Pharmacogenetics 7, 137-144.
55. Li, W.-F., Furlong, C. E., and Costa, L. G. (1995). Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol. Lett. 76, 219-226.
56. London, S. J., Lehman T. A., and Taylor, J. A. (1997). Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res 57, 5001-3.
57. Manabe, S., Tohyama, K., Wada, O., and Aramaki, T. (1991). Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in cigarette smoke condensate. Carcinogenesis 12, 1945-1947.
58. McGlynn, K. A., Rosvold, E. A., Lustbader, E. D., Hu, Y., Clapper, M. L., Zhou, T., Wild, C. P., Xia, X. L., Baffoe Bonnie, A., Ofori Adjei, D., et al. (1995). Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc. Natl. Acad. Sci. U S A 92, 2384-2387.
59. Minchin, R. F., Reeves, P. T., Teitel, C. H., McManus, M. E., Mojarrabi, B., Ilett, K. F., and Kadlubar, F. F. (1992). N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. Biochem. Biophys. Res. Comm. 185, 839-844.
60. Minnick, D. T., Astatke, M., Joyce, C. M. and Kunkel, T. A. (1996). A thumb subdomain mutant of the large fragment of Escherichia coli DNA polymerase I with reduced DNA binding affinity, processivity and frameshift fidelity, J. Biol. Chem. 271, 24954-24961.
61. Mueller, R. F., Hornung, S., Furlong C. E., Anderson, J., Gilbert, E. R., and Motulsky, A. G. (1983). Plasma paraoxonase polymorphism: A new enzyme assay, population, family, biochemical and linkage studies. Am. J. Hum. Genet. 35, 393-408.
62. Omiecinski, C. J., Aicher, L., and Swenson, L. (1994). Developmental expression of human microsomal epoxide hydrolase. J. Pharmacol. Exp. Ther. 269, 417-423.
63. Ortigoza-Ferado, J., Richter, R., Hornung, S. K., Motulsky, A.G. and Furlong, C. E. (1984). Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin. Am. J. Hum. Genet. 36, 295-305.
64. Packenham, J. P., Taylor J. A., Anna C. H., White C. M., and Devereux T. R. (1995). Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors. Mol. Carcinog. 14, 147-151.
65. Patrianakos, C., and Hoffman, D. (1979). Chemical studies on tobacco smoke, LXIV: On the analysis of aromatic amines in cigarette smoke. J. Anal. Toxicol. 3, 150-154.
66. Paulsen, J. E., Steffensen, I. L., Namourk, E., Hein, D. W., and Alexander, J. (1996). Effect of acetylator genotype on 3,2′-dimethyl-4-aminobiphenyl induced aberrant crypt foci in the colon of hamsters. Carcinogenesis 17, 459-465.
67. Pretlow, T. P., Barrow, B. J., Ashton, W. S., O'Riordan, M. A., Pretlow, T. G., Turcisek, J. A., and Stellate, T. A. (1991). Aberrant crypts: Putative preneoplastic foci in human colonic mucosa. Cancer Res. 51, 1564-1567.
68. Probst-Hensch, N. M., Haile, R. W., Ingles, S. A., Longnecker, M. P., Han, C. Y., Lin, B. K., Lee, D. B., Sakamota, G. T., Franski, H.D., Lee, E. R., and Lin, H. J. (1995). Acetylation polymorphism and prevalence of colorectal adenomas. Cancer Res. 55, 2017-2020.
69. Raaka, S., Hassett, C., and Omiecinski, C. J. (1998). Human microsomal epoxide hydrolase: 5′-flanking region genetic polymorphisms. Carcinogenesis 19, 387-393.
70. Rappaport, S. M., Yeowell-O'Connell, K., Bodell, W., Yager, J. W., and Symanski, E. (1996). An investigation of multiple biomarkers among workers exposed to styrene and styrene-7,8-oxide. Cancer Res. 56, 5410-5416.
71. Risinger, J. I., Umar, A., Boyd, J., Berchuck, A., Kunkel, T. A., and Barrett, J. C. (1996). Mutation of hMSH3 in endometrial cancers and evidence for its functional role in heteroduplex repair. Nat. Genet. 13, 102-105.
72. Roberts, J. D. and Kunkel, T. A. (1996) Fidelity of DNA replication. In DNA Replication in Eukaryotic Cells. (M. L. DePamphilis, Ed.), pp. 217-247. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
73. Roberts-Thomson, I. C., Ryan, P., Khoo, K. K., Hart, W. J., McMichael, A. J., and Butler, R. N. (1996). Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet 347, 1372-1374.
74. Rodriguez, J. W., Kirlin, W. G., Ferguson, R. J., Doll, M. A., Gray, K., Rustan, T. D., Lee, M. E., Kemp, K., Urso, P., and Hein, D. W. (1993). Human acetylator genotype: Relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression of colon cytosol. Arch. Toxicol. 67, 445-452.
75. Sayer, J. M., Yagi, H., van Bladeren, P. J., Levin, W., and Jerina, D. M. (1985). Stereoselectivity of microsomal epoxide hydrolase toward diol epoxides and tetrahydroepoxides derived from benz[a]anthracene. J. Biol. Chem. 260, 1630-1640.
76. Shibuta, K., Nakashima, T., Abe, M., Mashimo, M., Mon, M., Ueo, H., Akiyoshi, T., Sugimachi, K., and Suzuki, T. (1994). Molecular genotyping for N-acetylation polymorphism in Japanese patients with colorectal cancer. Cancer 74, 3108-3112.
77. Smith, C. A. and Harrison, D. J. (1997). Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350, 630-633.
78. Spurr, N. K., Gough, A. C., Chinegwundoh, F. I., Smith, C. A. D. (1995). Polymorphism in drug-metabolizing enzymes as modifiers of cancer risk. Clin. Chem. 41, 1864-1869.
79. Taylor, J.A., Umbach, D., Stephens, E., T. Castranio, D. Paulson, C. Robertson, J. Mohler, and D.A. Bell. (1998) The role of N-acetylation polymorphisms in smoking-associated bladder cancer: Evidence of a gene-gene exposure 3-way interaction Cancer Research (in press).
80. Thakker, D. R., Levin, W., Yagi, H., Yeh, H. J., Ryan, D. E., Thomas, P. E., Conney, A. H., and Jerina, D. M. (1986). Stereoselective metabolism of the (+MS1S)-and (-)-(R,R)-enantiomers of trans-3,4-dihydroxy-3,4-dihydrobenzo[c]-phenanthrene by rat and mouse liver microsomes and by a purified and reconstituted cytochrome P450 system. J. Biol. Chem. 261, 5404-5413.
81. Umar, A., and Kunkel, T. A. (1996). DNA replication fidelity, mismatch repair and genome instability in cancer cells. Eur. J. Biochem. 238, 297-307.
82. Umar, A., Koi, M., Risinger, J..I., Glaab, W., Tindall, K.. R., Kolodner, R. D., Boland, C. R., Barrett, J. C. and Kunkel, T. A. (1997). Correction of hypermutability, N-Methyl-N′-nitro-N-nitrosoguanidine-resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res. 57, 3949-3955.
83. Umar, A., Risinger, J. I., Glaab, W. E., Tindall, K. R., Barrett, J.C., and Kunkel, T. A. (1998). Functional overlap in mismatch repair by human MSH3 and MSH6. Genetics 148, 1637-1646.
84. Vatsis, K. P., Weber, W. W., Bell, D. A., Dupret, J.-M., Price-Evans, D. A., Grant, D. M., Hein, D. W., Lin, H. J., Meyer, U. A., Relling, M. V., Sim, E., Suzuki, T., and Yamazoe, Y. (1995). Nomenclature for N-acetyltransferases. Pharmacogenetics 5, 1-17.
85. Watson, A. D., Berline, J. A., Hama, S. Y., LaDu, B. N., Faull, K. F., Fogelman, A. F., and Navab, M. (1995). Protective effect of high density lipoprotein-associated paraoxonase: Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96, 2882-2891.
86. Weber, W. W., and Hein, D. W. (1985). N-acetylation pharmacogenetics. Pharmacol. Rev. 37, 25-79.
87. Welfare, M. R., Cooper, J., Bassendine, M. F., and Daly, A. K. (1997). Relationship between acetylator status, smoking, diet and colorectal cancer risk in the north-east of England. Carcinogenesis 18, 1351-1354.
88. Winter, D. B., Phung, Q. H., Umar, A., Baker, S. M., Tarone, R. E., Tanaka, K., Liskay, R. M., Kunkel, T. A., Bohr, V. A., and Gearhart, P. J. (1998). Altered spectra of hypermutation in antibodies from mice deficient for DNA mismatch repair. Proc. Natl. Acad. Sci. U S A (in press).
89. Wood, A. W., Chang, R. L., Levin, W., Kumar, S., Shirai, N., Jerina, D. M., Lehr, R. E., and Conney, A. H. (1986). Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine. Cancer Res. 46, 2760-2766.
90. Yamasaki, Y., Sakamoto, K., Watada, H. Kajimoto, Y. and Hori, M. (1997). The Arg 192 isoform of paraoxonase with low sarin-hydrolizing activity is dominant in Japanese. Hum. Genet. 101, 67-68.